Eurazeo SE

BATS-CHIXE:RFP Stock Report

Market Cap: €5.0b

Eurazeo Valuation

Is RFP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RFP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RFP (€69.85) is trading below our estimate of fair value (€416.83)

Significantly Below Fair Value: RFP is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RFP?

Key metric: As RFP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for RFP. This is calculated by dividing RFP's market cap by their current revenue.
What is RFP's PS Ratio?
PS Ratio14.9x
Sales€337.89m
Market Cap€5.05b

Price to Sales Ratio vs Peers

How does RFP's PS Ratio compare to its peers?

The above table shows the PS ratio for RFP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average11.3x
MNG M&G
0.8x-86.9%UK£4.7b
HICL HICL Infrastructure
22.4xn/aUK£2.4b
RCP RIT Capital Partners
8.6xn/aUK£2.7b
CLDN Caledonia Investments
13.6xn/aUK£1.8b
RFP Eurazeo
14.9x50.7%€5.0b

Price-To-Sales vs Peers: RFP is expensive based on its Price-To-Sales Ratio (14.9x) compared to the peer average (11.3x).

Price to Sales Ratio vs Industry

How does RFP's PS Ratio compare vs other companies in the GB Diversified Financial Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
NBS Nationwide Building Society
0.3xn/aUS$1.53b
LEND Sancus Lending Group
0.2x15.1%US$2.18m
No more companies available in this PS range
No. of Companies8PS01.22.43.64.86+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: RFP is expensive based on its Price-To-Sales Ratio (14.9x) compared to the UK Diversified Financial industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is RFP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RFP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio14.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate RFP's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst RFP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€69.85
€91.67
+31.2%
5.6%€100.00€83.00n/a6
Nov ’25€70.73
€92.00
+30.1%
6.7%€100.00€80.00n/a6
Oct ’25€73.80
€92.00
+24.7%
6.7%€100.00€80.00n/a6
Sep ’25€71.80
€92.33
+28.6%
6.0%€100.00€82.00n/a6
Aug ’25€72.33
€94.00
+30.0%
6.8%€100.00€82.00n/a6
Jul ’25€74.35
€94.00
+26.4%
6.4%€100.00€83.00n/a6
Jun ’25€77.80
€94.00
+20.8%
6.4%€100.00€83.00n/a6
May ’25n/a
€93.50
0%
7.8%€100.00€79.00n/a6
Apr ’25n/a
€93.50
0%
7.8%€100.00€79.00n/a6
Mar ’25n/a
€92.75
0%
8.5%€102.00€75.00n/a8
Feb ’25€76.23
€92.63
+21.5%
8.2%€100.00€75.00n/a8
Jan ’25n/a
€90.25
0%
8.3%€99.00€73.00n/a8
Dec ’24€64.53
€90.25
+39.9%
8.3%€99.00€73.00n/a8
Nov ’24n/a
€89.13
0%
9.0%€98.00€69.00€70.738
Oct ’24€55.78
€89.75
+60.9%
7.2%€98.00€74.00€73.808
Sep ’24n/a
€90.38
0%
5.3%€98.00€80.00€71.808
Aug ’24n/a
€90.88
0%
5.3%€98.00€80.00€72.338
Jul ’24€61.85
€94.38
+52.6%
7.6%€104.00€80.00€74.358
Jun ’24€62.90
€94.38
+50.0%
7.6%€104.00€80.00€77.808
May ’24€65.80
€93.14
+41.6%
8.0%€104.00€80.00n/a7
Apr ’24n/a
€93.14
0%
8.0%€104.00€80.00n/a7
Mar ’24€64.55
€87.14
+35.0%
10.1%€100.00€70.00n/a7
Feb ’24€64.85
€87.14
+34.4%
10.1%€100.00€70.00€76.237
Jan ’24€58.65
€87.14
+48.6%
10.1%€100.00€70.00n/a7
Dec ’23€61.10
€87.14
+42.6%
10.1%€100.00€70.00€64.537
Nov ’23€58.30
€90.50
+55.2%
11.0%€100.00€69.00n/a7

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

BFF Bank

€1.6b

Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.

0RON

€8.77

7D

-1.5%

1Y

-16.0%

Exor

€20.0b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

0RKY

€93.80

7D

-0.1%

1Y

5.2%

Man Group

UK£2.4b

Man Group Limited is a publicly owned investment manager.

EMGL

UK£2.09

7D

1.2%

1Y

-0.4%